Drug Interactions between Bevespi Aerosphere and respiratory syncytial virus immune globulin
This report displays the potential drug interactions for the following 2 drugs:
- Bevespi Aerosphere (formoterol/glycopyrrolate)
- respiratory syncytial virus immune globulin
Interactions between your drugs
No interactions were found between Bevespi Aerosphere and respiratory syncytial virus immune globulin. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Bevespi Aerosphere
A total of 516 drugs are known to interact with Bevespi Aerosphere.
- Bevespi aerosphere is in the drug class bronchodilator combinations.
- Bevespi aerosphere is used to treat the following conditions:
respiratory syncytial virus immune globulin
A total of 97 drugs are known to interact with respiratory syncytial virus immune globulin.
- Respiratory syncytial virus immune globulin is in the drug class immune globulins.
- Respiratory syncytial virus immune globulin is used to treat RSV.
Drug and food interactions
glycopyrrolate food
Applies to: Bevespi Aerosphere (formoterol / glycopyrrolate)
GENERALLY AVOID: Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous. In addition, the potential for abuse may be increased with the combination. The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system. No effect of oral propantheline or atropine on blood alcohol levels was observed in healthy volunteers when administered before ingestion of a standard ethanol load. However, one study found impairment of attention in subjects given atropine 0.5 mg or glycopyrrolate 1 mg in combination with alcohol.
MANAGEMENT: Alcohol should generally be avoided during therapy with anticholinergic agents. Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.
References (1)
- Linnoila M (1973) "Drug effects on psychomotor skills related to driving: interaction of atropine, glycopyrrhonium and alcohol." Eur J Clin Pharmacol, 6, p. 107-12
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.